To hear about similar clinical trials, please enter your email below
Trial Title:
The Influence of an E-learning Program on Recognition of Actinic Keratosis
NCT ID:
NCT05987553
Condition:
Actinic Keratoses
E-learning
Dermatology
Conditions: Official terms:
Keratosis, Actinic
Keratosis
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
e-learning program
Description:
All participants participate in this intervention: an e-learning program about the
recognition of actinic keratosis. The program exists of 30 cases. Each case exists of a
question and thorough explanation including references to various sources.
Arm group label:
General practitioners
Summary:
The evaluation on the diagnostic accuracy of actinic keratosis recognition by general
practitioners before and after participation on an e-learning program.
Detailed description:
Actinic keratosis is defined as the most frequent common intra-epithelial neoplasm in the
Caucasian population, with an increasing prevalence. If left untreated, actinic keratosis
has the potency to develop into a cutaneous squamous-cell carcinoma. Treatment of actinic
keratosis is aimed at both lesion reduction and to prevent malignant transformation. To
achieve treatment adherence for patients, it is necessary to raise physician awareness
about actinic keratosis.
This study primarily aimed to investigate whether the sensitivity of establishing a
correct actinic keratosis diagnosis by general practitioners (in training) would increase
after participating in an e-learning program about the recognition of actinic keratosis.
This was achieved by comparing the results of a pre- and post-test completed by general
practitioners which was incorporated in the e-learning program.
Criteria for eligibility:
Study pop:
Data from general practitioners who
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- general practitioner in the Netherlands
- access to e-learning module via phone/computer/tablet
- knowledge of the Dutch language
Exclusion Criteria:
- no knowledge of the Dutch language
- different specialists than general practitioner
Gender:
All
Minimum age:
18 Years
Maximum age:
67 Years
Locations:
Facility:
Name:
Ellen Oyen
Address:
City:
Maastricht
Country:
Netherlands
Start date:
January 1, 2021
Completion date:
December 1, 2024
Lead sponsor:
Agency:
Maastricht University Medical Center
Agency class:
Other
Source:
Maastricht University Medical Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05987553
